Skip to content
healthcare.dev

OLOPATADINE HYDROCHLORIDE

NDC 76162-044, OLOPATADINE HYDROCHLORIDE, solution, from TOPCO ASSOCIATES LLC.

Product NDC
76162-044
Status
Listed
Labeler
TOPCO ASSOCIATES LLC
Dosage form
SOLUTION
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209995
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76162-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
76162-044-39761620044391 BOTTLE, PLASTIC in 1 CARTON (76162-044-39) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 76162-044 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76162-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76162-044. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.